Cite
Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.
MLA
Bénard, Ludovic, et al. “Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of MTORC2/Akt Signaling.” Circulation, vol. 133, no. 15, Apr. 2016, pp. 1458–71. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.115.020678.
APA
Bénard, L., Jae Gyun Oh, Cacheux, M., Ahyoung Lee, Nonnenmacher, M., Matasic, D. S., Kohlbrenner, E., Changwon Kho, Pavoine, C., Hajjar, R. J., Hulot, J.-S., Oh, J. G., Lee, A., & Kho, C. (2016). Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling. Circulation, 133(15), 1458–1471. https://doi.org/10.1161/CIRCULATIONAHA.115.020678
Chicago
Bénard, Ludovic, Jae Gyun Oh, Marine Cacheux, Ahyoung Lee, Mathieu Nonnenmacher, Daniel S. Matasic, Erik Kohlbrenner, et al. 2016. “Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of MTORC2/Akt Signaling.” Circulation 133 (15): 1458–71. doi:10.1161/CIRCULATIONAHA.115.020678.